Actively Recruiting
Acute Ischemic Stroke Endovascular Therapy Registry Study A Multicenter Observational Study Evaluating Functional Outcomes and Safety
Led by Changhai Hospital · Updated on 2025-01-27
10000
Participants Needed
1
Research Sites
277 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to observe and assess the functional outcomes and safety of endovascular treatment for acute ischemic stroke caused by blockages in blood vessels of the brain's anterior or posterior circulation. It is a prospective, multicenter, observational trial with blinded outcome evaluation, focusing on patients treated in routine clinical settings. The main focus is on improving patients' functional abilities after treatment. The treatment studied involves endovascular methods such as mechanical thrombectomy using devices like stents, aspiration catheters, or combinations of these with intra-arterial thrombolysis. This approach targets removing the blood clot causing the stroke through minimally invasive catheter techniques performed in specialized facilities. Participants will be monitored for their functional recovery using the modified Rankin scale at 90 days after treatment. Researchers will collect data on safety and effectiveness during this period. The study does not specify age or gender limits and involves consent from the patient or their legal representative. There is no exclusion criteria beyond the inclusion requirements, emphasizing real-world clinical practice.
CONDITIONS
Official Title
Acute Ischemic Stroke EndoVascular Therapy: a Multicenter REGISTRY Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Acute ischemic stroke caused by anterior or posterior circulation vessel occlusion confirmed by computed tomography angiography (CTA) or magnetic resonance angiography (MRA) or digital subtraction angiography (DSA)
- Undergo intravascular therapy (i.e. access to a cath lab and an arterial puncture)
- The patient or his/her legal representative agreed to participate in the study and has signed the informed consent.
You will not qualify if you...
- No exclusion criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Jianimin Liu
Shanghai, China
Actively Recruiting
Research Team
P
Pengfei Yang, M.D.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here